| Literature DB >> 31215146 |
Jeong-Hoon Hahm1, ChoLong Jeong1, Hong Gil Nam1,2.
Abstract
Dietary restriction (DR) robustly delays the aging process in all animals tested so far. DR slows aging by negatively regulating the target of rapamycin (TOR) and S6 kinase (S6K) signaling pathway and thus inhibiting translation. Translation inhibition in C. elegans is known to activate the innate immune signal ZIP-2. Here, we show that ZIP-2 is activated in response to DR and in feeding-defective eat-2 mutants. Importantly, ZIP-2 contributes to the improvements in longevity and healthy aging, including mitochondrial integrity and physical ability, mediated by DR in C. elegans. We further show that ZIP-2 is activated upon inhibition of TOR/S6K signaling. However, DR-mediated activation of ZIP-2 does not require the TOR/S6K effector PHA-4/FOXA. Furthermore, zip-2 was not activated or required for longevity in daf-2 mutants, which mimic a low nutrition status. Thus, DR appears to activate ZIP-2 independently of PHA-4/FOXA and DAF-2. The link between DR, aging, and immune activation provides practical insight into the DR-induced benefits on health span and longevity.Entities:
Keywords: zzm321990C. eleganszzm321990; TOR/S6K; ZIP-2; dietary restriction; longevity; mitochondria
Mesh:
Substances:
Year: 2019 PMID: 31215146 PMCID: PMC6718572 DOI: 10.1111/acel.12982
Source DB: PubMed Journal: Aging Cell ISSN: 1474-9718 Impact factor: 9.304
Figure 1ZIP‐2 mediates dietary restriction effects in C. elegans. (a) Relative levels of irg‐1 mRNA in wild‐type (N2) and zip‐2 mutant worms on ad libitum (AL) and dietary restricted (DR) conditions at day 2 of adulthood. (b) The promoter activity of irg‐1 in AL wild‐type (n = 31), DR wild‐type (n = 29), AL zip‐2 mutant (n = 28), and DR zip‐2 mutant worms (n = 28) at day 2 of adulthood. (I) Pirg‐1::GFP expression patterns and (II) relative GFP intensity. GFP intensity of individual worms was normalized to the minimum GFP intensity value among all GFP intensity values. Scale bar: 100 μm. (c) Qualitative analysis of mitochondrial morphology in AL wild‐type (N2), DR wild‐type, AL zip‐2 mutant worms, and DR zip‐2 mutant worms during aging. Bars represent the proportion of worms with fragmented mitochondria. (d) MVs of wild‐type and zip‐2 mutant worms in AL or DR conditions during aging. (e) Survival rate curves of AL wild‐type (n = 69), DR wild‐type (n = 76), AL zip‐2 mutant worms (n = 70), and DR zip‐2 mutant worms (n = 86). Survival data are summarized in Table S1. (f) Increase in median lifespan of DR‐treated wild‐type and zip‐2 mutant worms compared with AL. (g) Increase in maximum lifespan of DR‐treated wild‐type and zip‐2 mutant worms compared with AL. Relative mRNA levels were determined by RT‐qPCR, normalized to act‐3. Error bars represent SEM. ns, not significant, *p < 0.05, **p < 0.01, ****p < 0.0001; unpaired t test
Figure 2ZIP‐2 activity is increased by inhibition of TOR/S6K pathway. (a) (I) Pirg‐1::GFP expression patterns with (n = 19) or without (n = 19) rapamycin in control RNAi and zip‐2 RNAi worms with rapamycin (n = 19). Scale bar: 100 μm. (II) Relative GFP intensity. GFP intensity of individual worms was normalized to the minimum GFP intensity value among all GFP intensity values. (b) Relative transcript levels of pha‐4, zip‐2, irg‐1, and irg‐2 in rsks‐1 mutant worms compared with wild‐type strains. (c, d) Relative expression levels of irg‐1 (c) and irg‐2 (d) in rsks‐1 mutant worms treated with control RNAi or zip‐2 RNAi. (e) Survival rate curves of wild‐type in control RNAi (n = 91), wild‐type in zip‐2 RNAi (n = 84), rsks‐1 mutant worms in control RNAi (n = 65), and rsks‐1 mutant worms in zip‐2 RNAi (n = 65). Survival data are summarized in Table S1. (f) Relative expression levels of zip‐2 and pha‐4 in eat‐2 mutant worms treated with control RNAi or pha‐4 RNAi. (g) Relative expression levels of zip‐2, irg‐1, irg‐2, and pha‐4 in eat‐2 mutant worms treated with control RNAi or zip‐2 RNAi. (h) Survival rate curves of wild‐type (N2) in control RNAi AL (n = 33), wild‐type in control RNAi DR (n = 40), zip‐2 mutant worms in control RNAi AL (n = 38) and in control RNAi DR (n = 38), and in pha‐4 RNAi DR (n = 50). Survival data are summarized in Table S1. (i) A schematic diagram for the ZIP‐2 activation in DR condition. Relative expression levels were determined by RT‐qPCR. All tested gene levels were normalized to act‐3. Error bars represent SEM. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; unpaired t test